Eurofins-Cerep SA
PAR:ALECR

Watchlist Manager
Eurofins-Cerep SA Logo
Eurofins-Cerep SA
PAR:ALECR
Watchlist
Price: 22 200 EUR 8.82% Market Closed
Market Cap: 111m EUR
Have any thoughts about
Eurofins-Cerep SA?
Write Note

Intrinsic Value

The intrinsic value of one ALECR stock under the Base Case scenario is 20 953.32 EUR. Compared to the current market price of 22 200 EUR, Eurofins-Cerep SA is Overvalued by 6%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALECR Intrinsic Value
20 953.32 EUR
Overvaluation 6%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Eurofins-Cerep SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ALECR cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ALECR?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Life Sciences Tools & Services Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Eurofins-Cerep SA

Provide an overview of the primary business activities
of Eurofins-Cerep SA.

What unique competitive advantages
does Eurofins-Cerep SA hold over its rivals?

What risks and challenges
does Eurofins-Cerep SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Eurofins-Cerep SA.

Provide P/S
for Eurofins-Cerep SA.

Provide P/E
for Eurofins-Cerep SA.

Provide P/OCF
for Eurofins-Cerep SA.

Provide P/FCFE
for Eurofins-Cerep SA.

Provide P/B
for Eurofins-Cerep SA.

Provide EV/S
for Eurofins-Cerep SA.

Provide EV/GP
for Eurofins-Cerep SA.

Provide EV/EBITDA
for Eurofins-Cerep SA.

Provide EV/EBIT
for Eurofins-Cerep SA.

Provide EV/OCF
for Eurofins-Cerep SA.

Provide EV/FCFF
for Eurofins-Cerep SA.

Provide EV/IC
for Eurofins-Cerep SA.

What are the Revenue projections
for Eurofins-Cerep SA?

How accurate were the past Revenue estimates
for Eurofins-Cerep SA?

What are the Net Income projections
for Eurofins-Cerep SA?

How accurate were the past Net Income estimates
for Eurofins-Cerep SA?

What are the EPS projections
for Eurofins-Cerep SA?

How accurate were the past EPS estimates
for Eurofins-Cerep SA?

What are the EBIT projections
for Eurofins-Cerep SA?

How accurate were the past EBIT estimates
for Eurofins-Cerep SA?

Compare the revenue forecasts
for Eurofins-Cerep SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Eurofins-Cerep SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Eurofins-Cerep SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Eurofins-Cerep SA compared to its peers.

Compare the P/E ratios
of Eurofins-Cerep SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Eurofins-Cerep SA with its peers.

Analyze the financial leverage
of Eurofins-Cerep SA compared to its main competitors.

Show all profitability ratios
for Eurofins-Cerep SA.

Provide ROE
for Eurofins-Cerep SA.

Provide ROA
for Eurofins-Cerep SA.

Provide ROIC
for Eurofins-Cerep SA.

Provide ROCE
for Eurofins-Cerep SA.

Provide Gross Margin
for Eurofins-Cerep SA.

Provide Operating Margin
for Eurofins-Cerep SA.

Provide Net Margin
for Eurofins-Cerep SA.

Provide FCF Margin
for Eurofins-Cerep SA.

Show all solvency ratios
for Eurofins-Cerep SA.

Provide D/E Ratio
for Eurofins-Cerep SA.

Provide D/A Ratio
for Eurofins-Cerep SA.

Provide Interest Coverage Ratio
for Eurofins-Cerep SA.

Provide Altman Z-Score Ratio
for Eurofins-Cerep SA.

Provide Quick Ratio
for Eurofins-Cerep SA.

Provide Current Ratio
for Eurofins-Cerep SA.

Provide Cash Ratio
for Eurofins-Cerep SA.

What is the historical Revenue growth
over the last 5 years for Eurofins-Cerep SA?

What is the historical Net Income growth
over the last 5 years for Eurofins-Cerep SA?

What is the current Free Cash Flow
of Eurofins-Cerep SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Eurofins-Cerep SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eurofins-Cerep SA

Current Assets 61m
Cash & Short-Term Investments 9.3m
Receivables 46.8m
Other Current Assets 4.9m
Non-Current Assets 11.7m
Long-Term Investments 17k
PP&E 9.2m
Intangibles 2.2m
Other Non-Current Assets 237k
Current Liabilities 11m
Accounts Payable 4.5m
Accrued Liabilities 3.5m
Other Current Liabilities 3m
Non-Current Liabilities 1.5m
Other Non-Current Liabilities 1.5m
Efficiency

Earnings Waterfall
Eurofins-Cerep SA

Revenue
46.2m EUR
Cost of Revenue
-6.7m EUR
Gross Profit
39.5m EUR
Operating Expenses
-31.3m EUR
Operating Income
8.2m EUR
Other Expenses
973k EUR
Net Income
9.2m EUR

Free Cash Flow Analysis
Eurofins-Cerep SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALECR Profitability Score
Profitability Due Diligence

Eurofins-Cerep SA's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
Positive Operating Income
61/100
Profitability
Score

Eurofins-Cerep SA's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

ALECR Solvency Score
Solvency Due Diligence

Eurofins-Cerep SA's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Eurofins-Cerep SA's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALECR Price Targets Summary
Eurofins-Cerep SA

There are no price targets for ALECR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALECR?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ALECR is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Eurofins-Cerep SA Logo
Eurofins-Cerep SA

Country

France

Industry

Life Sciences Tools & Services

Market Cap

111.9m EUR

Dividend Yield

0%

Description

Eurofins-Cerep SA engages in providing preclinical drug research services. The company is headquartered in Celle-Levescault, Nouvelle-Aquitaine and currently employs 211 full-time employees. The company went IPO on 2010-03-19. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The firm then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. In December 2013, it sold Cerep Inc, its American subsidiary, to Eurofins-Panlabs Inc, part of the Eurofins Scientific SE group.

Contact

NOUVELLE-AQUITAINE
Celle-Levescault
Le Bois l'Eveque
+33549893000
www.eurofins.fr

IPO

2010-03-19

Employees

211

Officers

MD, Director & Pres of The Eurofins Discovery Products France
Mr. Antoine Duthilleul
Gen. Counsel & Corp. Sec.
Ms. Sophie Macault

See Also

Discover More
What is the Intrinsic Value of one ALECR stock?

The intrinsic value of one ALECR stock under the Base Case scenario is 20 953.32 EUR.

Is ALECR stock undervalued or overvalued?

Compared to the current market price of 22 200 EUR, Eurofins-Cerep SA is Overvalued by 6%.

Back to Top